Nuvation Bio
NUVB
#5219
Rank
โ‚น156.49 B
Marketcap
โ‚น449.44
Share price
-1.46%
Change (1 day)
135.50%
Change (1 year)

Revenue for Nuvation Bio (NUVB)

Revenue in 2026 (TTM): โ‚น13.11 Billion

According to Nuvation Bio's latest financial reports the company's current revenue (TTM ) is โ‚น13.62 Billion. In 2025 the company made a revenue of โ‚น5.64 Billion an increase over the revenue in the year 2024 that were of โ‚น0.67 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Nuvation Bio from 2020 to 2026

Annual revenue

Year Revenue Change
2026 (TTM) โ‚น13.11 B132.32%
2025 โ‚น5.64 B736.05%
2024 โ‚น0.67 B
2023 N/A
2022 N/A
2021 N/A
2020 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ORIC Pharmaceuticals
ORIC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA